Summary
GlobalData's clinical trial report, “Addison's Disease (Primary or Chronic Adrenal Insufficiency) Global Clinical Trials Review, H2, 2018" provides an overview of Addison's Disease (Primary or Chronic Adrenal Insufficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Addison's Disease (Primary or Chronic Adrenal Insufficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Shire Plc
Concordia International Rx UK Ltd
Charleston Area Medical Center Health System Inc
Pfizer Inc
Ipsen SA
E. Merck KG
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Clinical Trials by G7 Countries: Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials 26
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 53
Abbreviations 53
Definitions 53
Research Methodology 54
Secondary Research 54
About GlobalData 54
Contact Us 55
Source 55
List of Tables
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region, 2018* 7
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 11
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, North America, Top Countries, 2018* 13
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2018* 15
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase, 2018* 18
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 19
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 21
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 24
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28
List of Figures
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Region (%), 2018* 7
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12
Proportion of Addison's Disease (Primary or Chronic Adrenal Insufficiency) to Hormonal Disorders Clinical Trials, G7 Countries (%), 2018* 14
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 16
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 17
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Phase (%), 2018* 18
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 19
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics, Global, Clinical Trials by Trial Status, 2018* 20
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 24
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Addison's Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28
GlobalData Methodology 54
